Trial Profile
Role of Alpha-cell GLP-1 in the Beta-cell Response to DPP-4 Inhibition
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Apr 2018 Status changed from recruiting to completed.
- 15 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 15 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.